Position in TLRY
as of Jun 30, 2026
· filed Sep 21, 2026
Position Value
$13
New position
Shares Held
3
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Silicon Valley Capital Partners holds $24,865 across 6 Drug Manufacturers - Specialty & Generic names. TLRY ranks #6 (0.1% of the industry book) .
All Filings in TLRY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13 | 3 | Shares | Sole | 2026-09-21 | |
| No filing history on record for this holder in this stock. | ||||||